About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,492 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,492 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1061-1080 of 7,492 trials

RecruitingExercise in Prostate CancerThe goal of this clinical trial is to learn how exercise intervention affects circulating tumor cells (CTC) in men with advanced prostate cancer.NCT06165302·Baltimore, Maryland CompletedHigh-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate CancerRATIONALE: Highly focused ultrasound energy may be able to kill cancer cells by heating the tumor without affecting the surrounding tissue.NCT00030277·Indianapolis, Indiana and 1 other RecruitingNeoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate CancerThis is a Phase I/II trial evaluating the effectiveness of adding neoadjuvant HDR-B prior to RALP for HR-PCa patients with selective AAB for decipher high risk or pathologically…NCT07182279·Houston, Texas UnknownA Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate CancerA single high dose rate brachytherapy (HDR) treatment combined with a short course of external beam radiotherapy (EBRT) is a highly effective and well tolerated treatment for men…NCT01890096·Toronto, Ontario

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedPrevention of Osteoporosis in Men With Prostate CancerThe purpose of this two year study is to examine the safety and effectiveness of alendronate (Fosamax) for the prevention of bone loss in men with prostate cancer who are on…NCT00048841·Pittsburgh, Pennsylvania

CompletedAn AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's ContinuumIn Europe, prostate cancer (PCa) is the second most frequent type of cancer in men and the fifth most lethal.NCT05384002·Candiolo, Italy

Active not recruitingEnzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate CancerThis phase 2 randomised clinical trial will investigate the activity and safety of adding Lu-PSMA to enzalutamide in patients with metastatic castrate resistant prostate cancer…NCT04419402·Camperdown, New South Wales and 14 others

RecruitingSL-28 for Advanced Solid TumoursSecond Life Therapeutics is developing SL-28, an allogeneic, non-genetically modified cell-based therapy for the treatment of advanced solid tumours.NCT07341737·Sydney, New South Wales and 2 others

RecruitingSHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPCThe aim of this study is to evaluate the efficacy of SHR-1701 in combination with SBRT in patients with metastatic castration-resistant prostate cancer.NCT07451795·Fujian and 2 others

TerminatedCancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )Multi-center,double blind randomized phase III placebo controlled study in 250 men with histologically proven prostate cancer with out bone metastases who are beginning ADT…NCT00236002

CompletedPET/MRI in Patients With Suspected Prostate CancerThis diagnostic clinical trial will be conducted according to a randomized, prospective, controlled, double-arm, single-centre design.NCT02659527·Vienna

RecruitingComprehensive Outcomes for After Cancer HealthThis study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have completed primary…NCT05349227·Gainesville, Florida and 6 others

Active not recruitingNew Treatment Modalities for Localized Prostate CancerThe purpose of this study is to evaluate the effectiveness of four of the nowadays most established primary treatments for patients with clinically localized prostate cancer…NCT05523856

CompletedHerbal Therapy for Treatment of Recurrent Prostate CancerThis study is about Prostate Health Cocktail, a combination supplement that contains vitamin D3, vitamin E, selenium, green tea extract, saw palmetto, lycopene, and soy…NCT00669656·Los Angeles, California

Active not recruitingDiagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSAThis randomized phase II trial studies how well systematic random biopsy or magnetic resonance imaging (MRI)-ultrasound image (US) fusion biopsy work in diagnosing prostate cancer…NCT03234556·Los Angeles, California and 3 others

CompletedA Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate CancerBackground: Prostate cancer (PCa) is the most common cancer for men. When treated early enough it is typically curable.NCT01716702·Halifax, Nova Scotia

CompletedPET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric StudyThe overall goal is to provide an innovative approach to restage patients with biochemical recurrence of prostate cancer by using hybrid PET/MR with innovative radiotracers…NCT05806853·Milan

CompletedMachine-learning Optimization for Prostate Brachytherapy PlanningThe proposed, mono-institutional, randomized-controlled trial aims to determine whether the dosimetric outcomes following prostate Low-Dose-Rate (LDR) brachytherapy, planned using…NCT02943824·Toronto, Ontario

RecruitingPhase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate AdenocarcinomaThis is a Phase I, open-label, single-center study evaluating the safety, tolerability, and recommended Phase II dose of docetaxel when combined with a fixed dose of…NCT07316686·São Paulo

CompletedMTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate CancerThis is a Phase I, non-randomized, multiple-dose, 3+3 dose-escalation study of the safety, pharmacokinetics, biomarkers, preliminary efficacy and patient-reported outcomes of…NCT00868595·Houston, Texas

PreviousPage 54 of 375Next